Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Challenging problems in advanced malignancy: Case 3. Imatinib mesylate-induced interstitial pneumonitis.

× No keyword cloud information.

5 in total

1. A case of chronic myeloid leukemia with eosinophilic interstitial pneumonitis after administration of imatinib mesylate for 11 months.

Authors: Koichiro Suemori; Hiroshi Fujiwara; Seiichiro Watanabe; Taichi Azuma; Masaki Yasukawa
Journal: Int J Hematol Date: 2010-11-26 Impact factor: 2.490

2. Imatinib mesylate-induced interstitial lung disease in a patient with prior history of Mycobacterium tuberculosis infection.

Authors: Na-Ri Lee; Ji Won Jang; Hee Sun Kim; Ho-Young Yhim
Journal: Korean J Intern Med Date: 2015-06-29 Impact factor: 2.884

3. Nilotinib-induced interstitial lung disease.

Authors: Se-Il Go; Won Sup Lee; Gyeong-Won Lee; Jung Hun Kang; Myung Hee Kang; Jeong-Hee Lee; Hoon-Gu Kim
Journal: Int J Hematol Date: 2013-07-23 Impact factor: 2.490

4. Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark).

Authors: Martin Henkes; Heiko van der Kuip; Walter E Aulitzky
Journal: Ther Clin Risk Manag Date: 2008-02 Impact factor: 2.423

Review 5. Repurposing of Kinase Inhibitors for Treatment of COVID-19.

Authors: Ellen Weisberg; Alexander Parent; Priscilla L Yang; Martin Sattler; Qingsong Liu; Qingwang Liu; Jinhua Wang; Chengcheng Meng; Sara J Buhrlage; Nathanael Gray; James D Griffin
Journal: Pharm Res Date: 2020-08-10 Impact factor: 4.580

5 in total